The New Jersey Supreme Court has found that drug maker Hoffman-LaRoche provided proper and adequate warnings to patients taking its acne medication Accutane. In so doing, it has effectively dismissed consolidated lawsuits filed by some 514 plaintiffs.
In its ruling, which was a 6-0 decision with one justice abstaining, the Court found that Accutane’s warnings had been approved by the FDA since 2002. “On the record before us, ...
continue reading...